Variant report
Variant | esv20357 |
---|---|
Chromosome Location | chr6:26949088-26968511 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:26962343..26965289-chr6:26986491..26988275,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238621 | chromatin interactions |
ENSG00000224843 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530136194 | chr6:26953000-26953001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549000571 | chr6:26953123-26953124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376999623 | chr6:26953157-26953158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376524131 | chr6:26953178-26953179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs534611167 | chr6:26953189-26953190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569935454 | chr6:26953274-26953275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551112863 | chr6:26953282-26953283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142050396 | chr6:26953305-26953306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536735771 | chr6:26953394-26953395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557051024 | chr6:26953415-26953416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567150257 | chr6:26953489-26953490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536285733 | chr6:26953496-26953497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6910264 | chr6:26953545-26953546 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs573531980 | chr6:26953552-26953553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545736310 | chr6:26953553-26953554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559159974 | chr6:26953561-26953562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376158176 | chr6:26953591-26953592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190923551 | chr6:26953658-26953659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544357115 | chr6:26953763-26953764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571659538 | chr6:26953854-26953855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2393823 | chr6:26954016-26954017 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs540578199 | chr6:26954067-26954068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560115364 | chr6:26954075-26954076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528336794 | chr6:26954121-26954122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186966506 | chr6:26954209-26954210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571090399 | chr6:26954279-26954280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530783263 | chr6:26954374-26954375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540739910 | chr6:26954379-26954380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190064837 | chr6:26954445-26954446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114271649 | chr6:26954456-26954457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535969794 | chr6:26954539-26954540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112109105 | chr6:26954556-26954557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552977295 | chr6:26954587-26954588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6916596 | chr6:26954634-26954635 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs569967765 | chr6:26954691-26954692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs3873208 | chr6:26954740-26954741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539323053 | chr6:26954747-26954748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559320576 | chr6:26954874-26954875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575905299 | chr6:26955036-26955037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186462356 | chr6:26955120-26955121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554764530 | chr6:26955121-26955122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377355109 | chr6:26955146-26955147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370931287 | chr6:26955147-26955148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs373761084 | chr6:26955153-26955154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377591799 | chr6:26955155-26955156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142527583 | chr6:26955178-26955179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113923853 | chr6:26955179-26955180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576284813 | chr6:26955189-26955190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191361835 | chr6:26955239-26955240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565280180 | chr6:26955246-26955247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21509527 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21364760 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:26953000-26953400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr6:26953000-26953600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr6:26953600-26966000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |